Pharmaceuticals, Biotechnology and Life Sciences
R&D effort refocused on two therapeutic areas with significant unmet medical needs: ACLF and cholestatic diseasesGENFIT well positioned to leverage…
Virtual R&D Day on May 25 to unveil SYK portfolio development strategy and highlight momentum of CDK9 inhibitor program and…
Management will host a conference call today at 4:30 p.m. (ET) to review financial results and provide a corporate updateWOBURN,…
– Topline efficacy results for ongoing Phase 3 study evaluating SB206 as a treatment for molluscum on track for targeted…
Conference call and webcast today at 4:30pm Eastern/1:30pm PacificMENLO PARK, Calif., May 11, 2021 (GLOBE NEWSWIRE) — Talis Biomedical Corporation…
SANTA MONICA, Calif., May 11, 2021 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines…
MELBOURNE, Australia and ISTANBUL, Turkey, May 10, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today…
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH…
-Firdapse® Q1 2021 Net Revenues of $30.2 Million -First Quarter 2021 GAAP Net Income of $7.7 Million; Non-GAAP Net Income…
– 58 subjects continue in the open-label extension study for TransCon PTH – COPENHAGEN, Denmark, May 10, 2021 (GLOBE NEWSWIRE)…